Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
De Novo Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
De Novo Ventures

De Novo Ventures

Inactive

De Novo Ventures LLC: A venture capital firm specializing in the growth of US healthcare, medical device, and biotech companies.

Location
Saratoga, CA, US
Founded
2003
Firm
Compare
Portfolio
Employees

Investments

Milo
Milo

Total Raised

$14.6M

Rounds

3

Series A$12MJanuary 2023
Benvenue Medical
Benvenue Medical
Acquired

Total Raised

$232.5M

Rounds

10

Series F$23MJanuary 2016
Series E$40MJune 2014
Series D$25MJune 2012
Series C$35.5MApril 2011
EndoGastric Solutions
EndoGastric Solutions

Total Raised

$380.2M

Rounds

22

Series G$30MMay 2014
Series B$13MJune 2012
Series Unknown$2.1MApril 2012
Series F$30MAugust 2010
Series E$21.5MNovember 2009
Series Unknown$9.5MOctober 2009
Series Unknown$3.8MJune 2009
Tria Beauty
Tria Beauty
Acquired

Total Raised

$288M

Rounds

15

Private Equity$45.5MJuly 2013
Series Unknown$7.5MOctober 2012
Series Unknown$26.3MFebruary 2011
Astute Medical
Astute Medical
Acquired

Total Raised

$209.1M

Rounds

9

Series C$40.4MJune 2012
Series B$13MMarch 2011
Series B$26.5MMay 2010
Viracta Therapeutics
Viracta Therapeutics
Public

Total Raised

$194.9M

Rounds

11

Series B$13MMarch 2012
Series B$12MApril 2010
Pulmonx
Pulmonx
Public

Total Raised

$276.9M

Rounds

12

Private Equity$10MJanuary 2012
Series C$32MMarch 2010
Simpirica Spine
Simpirica Spine

Total Raised

$27M

Rounds

3

Series C$22MSeptember 2011
Spiracur
Spiracur
Public

Total Raised

$75.5M

Rounds

4

Series C$35MFebruary 2011
Articulinx
Articulinx

Total Raised

$12.2M

Rounds

2

Series B$10MApril 2010